Liotta LA - Search Results

1

Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.

Gulmann C, Sheehan KM, Kay EW, Liotta LA, Petricoin EF 3rd. Gulmann C, et al. Among authors: liotta la. J Pathol. 2006 Apr;208(5):595-606. doi: 10.1002/path.1958. J Pathol. 2006. PMID: 16518808 Review.

2

Clinical potential of proteomics in the diagnosis of ovarian cancer.

Ardekani AM, Liotta LA, Petricoin EF 3rd. Ardekani AM, et al. Among authors: liotta la. Expert Rev Mol Diagn. 2002 Jul;2(4):312-20. doi: 10.1586/14737159.2.4.312. Expert Rev Mol Diagn. 2002. PMID: 12138495 Review.

3

Clinical proteomics for cancer biomarker discovery and therapeutic targeting.

Krieg RC, Paweletz CP, Liotta LA, Petricoin EF 3rd. Krieg RC, et al. Among authors: liotta la. Technol Cancer Res Treat. 2002 Aug;1(4):263-72. doi: 10.1177/153303460200100407. Technol Cancer Res Treat. 2002. PMID: 12625785 Free article. Review.

4

Proteomic applications for the early detection of cancer.

Wulfkuhle JD, Liotta LA, Petricoin EF. Wulfkuhle JD, et al. Among authors: liotta la. Nat Rev Cancer. 2003 Apr;3(4):267-75. doi: 10.1038/nrc1043. Nat Rev Cancer. 2003. PMID: 12671665 Review.

5

Clinical applications of proteomics.

Petricoin EF, Liotta LA. Petricoin EF, et al. Among authors: liotta la. J Nutr. 2003 Jul;133(7 Suppl):2476S-2484S. doi: 10.1093/jn/133.7.2476S. J Nutr. 2003. PMID: 12840227 Review.

6

Proteomic approaches in cancer risk and response assessment.

Petricoin EF, Liotta LA. Petricoin EF, et al. Among authors: liotta la. Trends Mol Med. 2004 Feb;10(2):59-64. doi: 10.1016/j.molmed.2003.12.006. Trends Mol Med. 2004. PMID: 15102358 Review.

7

SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer.

Petricoin EF, Liotta LA. Petricoin EF, et al. Among authors: liotta la. Curr Opin Biotechnol. 2004 Feb;15(1):24-30. doi: 10.1016/j.copbio.2004.01.005. Curr Opin Biotechnol. 2004. PMID: 15102462

8

Clinical proteomics: Applications for prostate cancer biomarker discovery and detection.

Petricoin EF, Ornstein DK, Liotta LA. Petricoin EF, et al. Among authors: liotta la. Urol Oncol. 2004 Jul-Aug;22(4):322-8. doi: 10.1016/j.urolonc.2004.04.011. Urol Oncol. 2004. PMID: 15283891 Review.

9

Opportunities for nanotechnology-based innovation in tissue proteomics.

Geho DH, Lahar N, Ferrari M, Petricoin EF, Liotta LA. Geho DH, et al. Among authors: liotta la. Biomed Microdevices. 2004 Sep;6(3):231-9. doi: 10.1023/B:BMMD.0000042053.51016.b4. Biomed Microdevices. 2004. PMID: 15377833 Review.

10

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

Sheehan KM, Calvert VS, Kay EW, Lu Y, Fishman D, Espina V, Aquino J, Speer R, Araujo R, Mills GB, Liotta LA, Petricoin EF 3rd, Wulfkuhle JD. Sheehan KM, et al. Among authors: liotta la. Mol Cell Proteomics. 2005 Apr;4(4):346-55. doi: 10.1074/mcp.T500003-MCP200. Epub 2005 Jan 25. Mol Cell Proteomics. 2005. PMID: 15671044 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

691 results

Search Page

Filters